Fulcrum Therapeutics Stock Price History
FULC Stock | USD 7.10 0.55 7.19% |
If you're considering investing in Fulcrum Stock, it is important to understand the factors that can impact its price. As of today, the current price of Fulcrum Therapeutics stands at 7.10, as last reported on the 22nd of July, with the highest price reaching 7.81 and the lowest price hitting 7.03 during the day. Fulcrum Therapeutics is relatively risky given 3 months investment horizon. Fulcrum Therapeutics secures Sharpe Ratio (or Efficiency) of 0.22, which denotes the company had a 0.22 % return per unit of risk over the last 3 months. We were able to break down and interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.27% are justified by taking the suggested risk. Use Fulcrum Therapeutics Downside Deviation of 3.3, coefficient of variation of 471.53, and Mean Deviation of 3.56 to evaluate company specific risk that cannot be diversified away. Fulcrum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sharpe Ratio = 0.2207
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | FULC | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.78 actual daily | 51 51% of assets are less volatile |
Expected Return
1.27 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Fulcrum Therapeutics is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fulcrum Therapeutics by adding it to a well-diversified portfolio.
Fulcrum Therapeutics Stock Price History Chart
There are several ways to analyze Fulcrum Stock price data. The simplest method is using a basic Fulcrum candlestick price chart, which shows Fulcrum Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | July 10, 2025 | 8.01 |
Lowest Price | April 24, 2025 | 3.51 |
Fulcrum Therapeutics July 22, 2025 Stock Price Synopsis
Various analyses of Fulcrum Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Fulcrum Stock. It can be used to describe the percentage change in the price of Fulcrum Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Fulcrum Stock.Fulcrum Therapeutics Price Rate Of Daily Change | 0.93 | |
Fulcrum Therapeutics Price Action Indicator | (0.60) | |
Fulcrum Therapeutics Accumulation Distribution | 59,875 | |
Fulcrum Therapeutics Price Daily Balance Of Power | (0.71) |
Fulcrum Therapeutics July 22, 2025 Stock Price Analysis
Fulcrum Stock Price History Data
The price series of Fulcrum Therapeutics for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 4.5 with a coefficient of variation of 19.43. Under current investment horizon, the daily prices are spread out with arithmetic mean of 6.42. The median price for the last 90 days is 6.88.Open | High | Low | Close | Volume | ||
07/21/2025 | 7.65 | 7.81 | 7.03 | 7.10 | 599,513 | |
07/18/2025 | 8.03 | 8.10 | 7.63 | 7.65 | 388,522 | |
07/17/2025 | 7.86 | 8.02 | 7.77 | 7.94 | 220,721 | |
07/16/2025 | 7.88 | 8.03 | 7.68 | 7.88 | 302,329 | |
07/15/2025 | 7.92 | 8.04 | 7.62 | 7.84 | 338,397 | |
07/14/2025 | 7.70 | 8.14 | 7.57 | 7.90 | 531,562 | |
07/11/2025 | 7.92 | 8.26 | 7.82 | 7.83 | 678,593 | |
07/10/2025 | 7.92 | 8.03 | 7.35 | 8.01 | 590,043 | |
07/09/2025 | 7.98 | 8.18 | 7.70 | 7.91 | 937,800 | |
07/08/2025 | 7.09 | 7.93 | 6.99 | 7.85 | 1,159,367 | |
07/07/2025 | 6.86 | 7.25 | 6.75 | 7.02 | 427,200 | |
07/03/2025 | 6.95 | 6.95 | 6.65 | 6.92 | 146,400 | |
07/02/2025 | 6.82 | 7.10 | 6.56 | 6.93 | 381,938 | |
07/01/2025 | 6.59 | 6.91 | 6.16 | 6.84 | 871,419 | |
06/30/2025 | 7.10 | 7.27 | 6.87 | 6.88 | 992,147 | |
06/27/2025 | 7.43 | 7.70 | 6.98 | 7.10 | 816,963 | |
06/26/2025 | 7.19 | 7.40 | 7.06 | 7.38 | 363,060 | |
06/25/2025 | 7.17 | 7.26 | 6.95 | 7.16 | 252,874 | |
06/24/2025 | 7.30 | 7.48 | 7.15 | 7.19 | 513,103 | |
06/23/2025 | 6.98 | 7.45 | 6.83 | 7.17 | 1,011,931 | |
06/20/2025 | 6.37 | 7.21 | 6.28 | 7.00 | 607,100 | |
06/18/2025 | 6.42 | 6.74 | 6.33 | 6.36 | 386,733 | |
06/17/2025 | 6.78 | 6.87 | 6.33 | 6.43 | 685,257 | |
06/16/2025 | 6.83 | 6.97 | 6.61 | 6.80 | 660,322 | |
06/13/2025 | 6.60 | 6.93 | 6.60 | 6.85 | 247,184 | |
06/12/2025 | 6.74 | 6.92 | 6.66 | 6.78 | 289,809 | |
06/11/2025 | 6.93 | 7.17 | 6.68 | 6.83 | 453,732 | |
06/10/2025 | 7.12 | 7.23 | 6.89 | 6.90 | 380,679 | |
06/09/2025 | 7.30 | 7.39 | 6.99 | 7.12 | 229,500 | |
06/06/2025 | 7.23 | 7.40 | 7.10 | 7.25 | 377,324 | |
06/05/2025 | 7.03 | 7.40 | 6.89 | 7.11 | 336,903 | |
06/04/2025 | 7.03 | 7.10 | 6.83 | 7.03 | 350,435 | |
06/03/2025 | 6.96 | 7.17 | 6.82 | 7.04 | 430,900 | |
06/02/2025 | 6.97 | 7.11 | 6.64 | 6.96 | 381,265 | |
05/30/2025 | 7.02 | 7.08 | 6.67 | 6.88 | 396,100 | |
05/29/2025 | 7.11 | 7.47 | 6.98 | 7.07 | 751,206 | |
05/28/2025 | 6.28 | 7.00 | 6.23 | 6.90 | 991,983 | |
05/27/2025 | 6.55 | 6.82 | 6.03 | 6.35 | 492,900 | |
05/23/2025 | 6.82 | 7.04 | 6.25 | 6.44 | 898,657 | |
05/22/2025 | 6.18 | 6.27 | 5.90 | 6.12 | 427,616 | |
05/21/2025 | 6.40 | 6.80 | 6.23 | 6.25 | 325,200 | |
05/20/2025 | 6.92 | 6.99 | 6.25 | 6.51 | 753,254 | |
05/19/2025 | 6.75 | 7.04 | 6.52 | 6.93 | 740,200 | |
05/16/2025 | 6.69 | 7.06 | 6.31 | 6.88 | 1,033,281 | |
05/15/2025 | 5.99 | 6.63 | 5.65 | 6.60 | 1,166,648 | |
05/14/2025 | 5.80 | 5.86 | 5.51 | 5.63 | 620,100 | |
05/13/2025 | 5.75 | 5.87 | 5.53 | 5.79 | 351,431 | |
05/12/2025 | 5.37 | 5.82 | 5.37 | 5.68 | 544,200 | |
05/09/2025 | 5.42 | 5.70 | 5.28 | 5.37 | 512,411 | |
05/08/2025 | 5.06 | 5.55 | 4.91 | 5.41 | 430,684 | |
05/07/2025 | 5.40 | 5.43 | 4.78 | 5.07 | 1,022,247 | |
05/06/2025 | 5.64 | 5.75 | 5.14 | 5.35 | 889,059 | |
05/05/2025 | 5.41 | 5.74 | 5.10 | 5.73 | 1,456,118 | |
05/02/2025 | 4.41 | 6.15 | 4.38 | 5.62 | 4,143,316 | |
05/01/2025 | 3.84 | 4.69 | 3.73 | 4.38 | 926,600 | |
04/30/2025 | 3.61 | 3.91 | 3.55 | 3.85 | 552,729 | |
04/29/2025 | 3.57 | 3.76 | 3.54 | 3.65 | 295,554 | |
04/28/2025 | 3.53 | 3.61 | 3.45 | 3.57 | 141,122 | |
04/25/2025 | 3.50 | 3.53 | 3.39 | 3.53 | 229,025 | |
04/24/2025 | 3.61 | 3.62 | 3.44 | 3.51 | 210,233 | |
04/23/2025 | 3.84 | 3.87 | 3.50 | 3.59 | 705,629 |
About Fulcrum Therapeutics Stock history
Fulcrum Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fulcrum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fulcrum Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fulcrum Therapeutics stock prices may prove useful in developing a viable investing in Fulcrum Therapeutics
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Fulcrum Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 104 people.
Fulcrum Therapeutics Stock Technical Analysis
Fulcrum Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
Fulcrum Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fulcrum Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Fulcrum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fulcrum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.206 | |||
Jensen Alpha | 1.11 | |||
Total Risk Alpha | 0.3671 | |||
Sortino Ratio | 0.3218 | |||
Treynor Ratio | 1.88 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Fulcrum Stock analysis
When running Fulcrum Therapeutics' price analysis, check to measure Fulcrum Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulcrum Therapeutics is operating at the current time. Most of Fulcrum Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fulcrum Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulcrum Therapeutics' price. Additionally, you may evaluate how the addition of Fulcrum Therapeutics to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |